Discover
VYNE
VYNE Therapeutics Inc.
0.88
5 x 0.88
1 x 0.89
bid
ask
-
0.01
1.42%
09:20 AM
timesize
| Ytd | 51.70% | |
| 1y | -21.43% |
day range
0.29
52 week range
1.46
| Open | Prev Close | 0.89 | Low | High | Mkt Cap | 14.88M | |||
| Vol | 80.31K | Avg Vol | 676.49K | EPS | -0.66 | P/E | -1.35 | Forward P/E | -2.95 |
| Beta | 2.00 | Short Ratio | 0.65 | Inst. Own | 51.92% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-18 | 50-d Avg | 0.68 | 200-d Avg | 0.56 | 1yr Est | 6.19 |
| Income Statement | |||
| Total Revenue | 86.00K | ||
| Revenues (USD) | 86.00K | ||
| Gross Profit | 86.00K | ||
| Operating Expenses | 3.90M | ||
| Research and Development Expense | 817.00K | ||
| Selling, General and Administrative Expense | 3.09M | ||
| Operating Income | -3.82M | ||
| Net Income | -3.58M | ||
| Net Income Common Stock | -3.58M | ||
| Net Income Common Stock (USD) | -3.58M | ||
| Consolidated Income | -3.58M | ||
| Earnings per Basic Share | -0.08 | ||
| Earnings per Basic Share (USD) | -0.08 | ||
| Earnings per Diluted Share | -0.08 | ||
| Earning Before Interest & Taxes (EBIT) | -3.58M | ||
| Earning Before Interest & Taxes (USD) | -3.58M | ||
| Weighted Average Shares | 42.77M | ||
| Weighted Average Shares Diluted | 42.77M | ||
| Balance Sheet | |||
| Cash and Equivalents | 24.63M | ||
| Cash and Equivalents (USD) | 24.63M | ||
| Investments | 297.00K | ||
| Investments Current | 297.00K | ||
| Current Assets | 25.79M | ||
| Property, Plant & Equipment Net | 84.00K | ||
| Total Assets | 25.87M | ||
| Current Liabilities | 1.24M | ||
| Total Liabilities | 1.24M | ||
| Accumulated Retained Earnings (Deficit) | -761.24M | ||
| Shareholders Equity | 24.64M | ||
| Shareholders Equity (USD) | 24.64M | ||
| Assets Non-Current | 84.00K | ||
| Trade and Non-Trade Payables | 261.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 6.00K | ||
| Net Cash Flow from Financing | -15.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 604.00K | ||
| Net Cash Flow from Investing | 4.70M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 4.70M | ||
| Net Cash Flow from Operations | -4.08M | ||
| Share Based Compensation | 474.00K | ||